Galvanize Therapeutics Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
171
- Latest Deal Type
-
2ndary - Private
- Investors
-
12
Galvanize Therapeutics General Information
Description
Developer of energy-based medical device technology designed to promote biological processes. The company's tool utilizes short-duration and high-voltage electrical pulses to create an electric field that destabilizes cells through multiple biochemical processes, enabling medical professionals to deliver improved healthcare services to patients.
Contact Information
Website
www.galvanizetx.comCorporate Office
- 3200 Bridge Parkway
- Redwood City, CA 94065
- United States
Corporate Office
- 3200 Bridge Parkway
- Redwood City, CA 94065
- United States
Galvanize Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 3. Later Stage VC (Series C) | 07-Jul-2025 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series B) | 29-Mar-2022 | $100M | $106M | Completed | Generating Revenue | |
| 1. Later Stage VC (Series A) | 28-Oct-2020 | $6.1M | $6.1M | Completed | Startup |
Galvanize Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Galvanize Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Galvanize Therapeutics Patents
Galvanize Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260354896-A1 | Tissue modification systems and methods and signal generators for use therewith | Pending | 14-Jul-2026 | ||
| AU-2025270275-A1 | Mucus disimpaction of the lung | Pending | 10-May-2024 | ||
| WO-2025235871-A1 | Mucus disimpaction of the lung | Pending | 10-May-2024 | ||
| US-20260177552-A1 | Quantification of immunological status and treatment planning | Pending | 22-Aug-2023 | ||
| WO-2025043024-A2 | Quantification of immunological status and treatment planning | Inactive | 22-Aug-2023 | G01N33/57585 |
Galvanize Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Galvanize Therapeutics Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ally Bridge Group | Growth/Expansion | Minority | ||
| Elevage Medical Technologies | Growth/Expansion | Minority | ||
| Janus Henderson Investors | Asset Manager | Minority | ||
| Longaeva Partners | Hedge Fund | Minority | ||
| Perceptive Advisors | Venture Capital | Minority |
Galvanize Therapeutics Acquisitions (3)
Galvanize Therapeutics’s most recent deal was a Merger/Acquisition with Shuneng Medical. The deal was made on 04-Sep-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Shuneng Medical | 04-Sep-2025 | Merger/Acquisition | Therapeutic Devices | ||
| Gala Therapeutics | 15-Sep-2022 | Merger/Acquisition | Therapeutic Devices | ||
| Galaxy Medical | 15-Sep-2022 | Merger/Acquisition | Diagnostic Equipment |
Galvanize Therapeutics Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Shuneng Medical | Shanghai, China | 2021 |
Galvanize Therapeutics FAQs
-
When was Galvanize Therapeutics founded?
Galvanize Therapeutics was founded in 2015.
-
Where is Galvanize Therapeutics headquartered?
Galvanize Therapeutics is headquartered in Redwood City, CA.
-
What is the size of Galvanize Therapeutics?
Galvanize Therapeutics has 171 total employees.
-
What industry is Galvanize Therapeutics in?
Galvanize Therapeutics’s primary industry is Therapeutic Devices.
-
Is Galvanize Therapeutics a private or public company?
Galvanize Therapeutics is a Private company.
-
What is Galvanize Therapeutics’s current revenue?
The current revenue for Galvanize Therapeutics is .
-
How much funding has Galvanize Therapeutics raised over time?
Galvanize Therapeutics has raised $206M.
-
Who are Galvanize Therapeutics’s investors?
Ally Bridge Group, Elevage Medical Technologies, Janus Henderson Investors, Longaeva Partners, and Perceptive Advisors are 5 of 12 investors who have invested in Galvanize Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
